ArticleOncology letters2025
Prolonged survival of a case with three different malignancies - cutaneous malignant melanoma, gastrointestinal stromal tumor and thyroid papillary cancer: A case report.
Article in Oncology letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This case report presents an extraordinary instance of a patient diagnosed with three separate primary malignancies: gastrointestinal stromal tumor (GIST), papillary thyroid carcinoma (PTC) and cutaneous malignant melanoma. The occurrence of such a combination of multiple primary cancers in a single individual is exceptionally rare, and to our knowledge, has not been previously documented in the medical literature. The patient underwent a comprehensive treatment regimen, including surgery and adjuvant imatinib for GIST, thyroidectomy, radioactive iodine therapy for PTC, as well as a combination of systemic and local treatments for metastatic malignant melanoma. Of note, the patient achieved a significantly prolonged survival, particularly in the context of metastatic melanoma, which is generally associated with a poor prognosis. This case underscores the effectiveness of a multidisciplinary and targeted treatment approach in managing complex cases involving multiple malignancies. It also emphasizes the potential benefits of integrating various oncological therapies, including tyrosine kinase inhibitors and immunotherapy, to achieve favorable outcomes in patients with multiple primary cancers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.